Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden

Ann Olsson , Liacine Bouaoun , Anssi Auvinen , Maria Feychting , Christoffer Johansen , Tiit Mathiesen , Béatrice Melin , Anna Lahkola , Suvi Larjavaara , Anne-Sophie Villegier (1, 2) , Graham Byrnes , Isabelle Deltour , Joachim Schuz

1 INERIS - Institut National de l'Environnement Industriel et des Risques
2 PERITOX - Périnatalité et Risques Toxiques - UMR INERIS_I 1

Gliomas are the most common cancer of the brain. We investigated whether pre-diagnostic mobile phone use was associated with survival. Glioma cases (n=806) in the INTERPHONE study in Denmark, Finland and Sweden were followed up for survival via registry linkages. Cox regression models were used to calculate hazard ratios and 95% confidence intervals. No reduced survival among glioblastoma patients was observed for various measures of mobile phone use relative to no or non-regular use. All significant associations suggested better survival for mobile phone users. Results were similar for high–grade and low–grade gliomas. In conclusion we found no evidence of reduced survival among glioma patients in relation to previous mobile phone use.

Domains: Life Sciences [q-bio]; Toxicology

Ann Olsson, Liacine Bouaoun, Anssi Auvinen, Maria Feychting, Christoffer Johansen, et al.. Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden. Annual meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association (BioEM 2019), Jun 2019, Montpellier, France. ⟨ineris-03229551⟩